Topics: drug administration, pharmacokinetics, membrane trnasport, distribution of drugs, kinetics of elimination, receptor pharmacology, drug development, clinical pharmacology, adverse drug effects, autonomic nervous system, cholinergic transmission, cholinergic drugs, anticholinergic drugs, autonomic ganglia, adrenergic transmission, adrenergic drugs, antiadrenergic drugs, adrenergic receptor antagonists, glaucoma, autacoids, histamine, antihistaminics, 5-hydroxytryptamine, migraine, prostaglandins, leukotrienes, eicosanoids, platelet activating factor, nonsteroidal antiinflammatory drugs, antipyretic-analgesics, antirheumatoid drugs, antigout drugs, respiratory system drugs, cough, bronchial asthma, hormones, anterior pituitary hormones, thyroid hormones, thyroid inhibitors, insulin, oral antidiabetic drugs, glucagon, corticosteroid, androgen, erectile dysfunction, estrogen, progestin, contraceptives, oxytocin, calcium balance, skeletal muscle relaxants, peripheral nervous system, somatic nervous system, local anaesthetics, central nervous system, general anaesthetics, ethyl, methyl, sedative-hypnotics, antiepileptic drugs, antiparkinsonian drugs, mental illness, antipsychotic, antimanic, antidepressant, antianxiety, Opioid analgesiscs, antagonists, CNS stimulants, cognition enhancers, cardiovascular drugs, cardiac electrophysiological considerations, renin-angiotensin system, nitric oxide, vasoactive peptide signal molecules, cardiac glycoside, heart failure, antiarrhythmic drugs, antianginal drugs, anti-ischaemic drugs, antihypertensive drugs, diuretics, urine formation, antidiuretics, blood formation, haematinics, erythropoietin, hypolipidaemic drugs, peptic ulcer, gastroesophageal reflux disease, antiemetic drugs, prokinetic drugs, digestant drugs, constipation, diarrhoea, antimicrobial drugs, sulfonamides, beta-lactam antibiotics, tetracycline, chloramphenicol, broad spectrum antibiotics, aminoglycoside antibiotics, macrolide, lincosamide, glycopeptide, antibacterial antibiotics, urinary antiseptics, antitubercular, antileprotic drugs, antifungal, antiviral, anticancer

Topics: Drug Sources, Drug Benefit Assessment, Congeneric Drugs, Drug Administration, Oral Dosage Forms, dermatological agents, drug distribution, Drug Action, membrance permeation, drug transporters, drug elimination, drug metabolism, enteroheptaic circulation, presystemic elimination, pharmacokinetics, druig concentration, accumulation, dose-response relationship, drug-receptor interaction, agonists-antagonists, enantioselectivity, G-protein-couples receptors, plasma concentration, adverse drug effects, drug allergy, cutaenous reactions, pregnancy, lactation, drug-independent effects, cutaneous reaction, placebo theraphy, systems pharmacology, sympathetic system, cathecholamine actions, sympathomimetics, indirect sympathomimetics, Parasympathetic Nervous System, Parasympathetic Functions, Cholinergic Synapse, Parasympathomimetics, Parasympatholytics, biogenic agents, dopamine, histamine, serotonin, amino acids, vasodilators, organic nitrates, calcium antagonists, Renin-Angiotensin-Aldosterone System, ACE Inhibitors, smooth muscle, cardiac Drugs, Cardiac Glycosides, antiarrhythmic drugs, antianemic agents, anemias, iron compounds, antithrombotic agents, thrombosis therapy, Vitamin K, Heparin, fibrinolytics, platelet aggregation, plasma volume expanders, hyperlipoproteinemias, lipid-lowering agents, diuretics, water reabsorption, vasopressin, water and electrolyte disorders, Gastrointestinal Tract, Hyperacidity, antidiarrheal agents, motor system, muscle relaxants, nociceptors, pain, analgesics, eicosanoids, antipyretic analgesics, local anesthetics, opioids, General Anesthesia and General Anesthetic Drugs.lnhalational Anesthetics, Injectable Anesthetics, Anxiolytics, benzodiazepines, depressive illness, manic state, schizophrenia, endocrine system, hypothalamic hormone, hypophyseal hormone, thyroid hormone therapy, hyperthroidism, antithyroid drugs, glucocorticoid therapy, androgen, anabolic steroid, antiandrogen, follicular growth, ovulation, antibacterial drugs, antifungal drugs, antiviral drugs, antiparasitic drugs, tropical diseases, anticancer drugs, immune modulators

Topics: Drug Therapy, Pharmacokinetics, Drug–Receptor Interactions, Pharmacodynamics, Autonomic Nervous System, Cholinergic Agonists, Cholinergic Antagonists, Adrenergic Agonists, Adrenergic Antagonists, Neurodegenerative Diseases, Anxiolytic drugs, Hypnotic Drugs, Antidepressants, Antipsychotic Drugs, Anesthetics, Opioids, CNS Stimulants, Antihypertensives, diuretics, Heart Failure, epilepsy, Antiarrhythmics, Antianginal Drugs, Anticoagulants, Antiplatelet Agents, Hyperlipidemia, Endocrine System, Pituitary, Thyroid, diabetes, estrogen, androgen, adrenal hormone, bone metabolism, Chemotherapeutic Drugs, Antimicrobial Therapy, Cell Wall Inhibitors, Protein Synthesis Inhibitors, Quinolones, Folic Acid Antagonists, Urinary Tract Antiseptics, Antimycobacterial Drugs, Antifungal Drugs, Antiviral Drugs, Anticancer Drugs, Immunosuppressants, Histamine, Serotonin, Anti-inflammatory Agents, Antipyretic Agents, Analgesic Agents, Gastrointestinal drugs, Antiemetic Drugs, Urologic Disorders, anemia, Dermatologic Disorders, Clinical Toxicology, drugs of abuse, Antiprotozoal Drugs, Anthelmintic Drugs

Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs